Video Observed Therapy Device Improves Probability of Tuberculosis Therapy Adherence; A Randomised Clinical Trial at a TB Reference Clinic in Lagos

Author:

Amoo Olufemi1,Kareithi Dorcas2,Tijani Bosun3,Onuigbo Tochukwu1,Karera Steven3,Oladejo Busayo3,Oraegbu Joy1,Ezike Jennifer1,Adekoya Adepeju1,Sani Maryam1,David Nkiru1,Audu Rosemary1,Salako Babatunde1

Affiliation:

1. Nigerian Institute of Medical Research

2. Newcastle University

3. Co-creation Hub, Nigeria

Abstract

Abstract

Background Video Observed Therapy (VOT) is a method of adherence monitoring where participants transmit digital images of their treatment intake to a central location for review; either synchronously or asynchronously. VOT presents an option that can be explored for developing countries like Nigeria with a high TB burden, thereby reducing the TB burden and ultimately eliminating it. Methods The study was a two-arm individually randomised clinical trial conducted by Nigeria Institute of Medical Research (NIMR) in Lagos, Nigeria. Participants (100) were recruited to this study and randomised into either treatment (VOT) or DOT (Directly Observed Therapy) as control. Data were collected through the NimCure mobile app and participant records. We compared treatment outcomes between VOT and DOT and assessed average treatment effects by adjusting for gender, location (state), and age. Results A high rate of 100% adherence to TB treatment was achieved in VOT (97%) and DOT (79%). More females than males achieved 100% adherence to VOT, while more males achieved 100% adherence to DOT. Rural dwellers achieved 100% adherence to both VOT and DOT. There was a varied distribution across all age groups. The average adherence, if all participants were to use VOT, would be 0.1709 (z = 2.23, p = 0.026) more than the average that would be if the participants did not use VOT. Conclusion VOT through the NimCure application achieved the adherence objective and showed that VOT can be used for effective remote monitoring and management of Tuberculosis in Nigeria. NimCure can therefore be recommended for use in low-income settings.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3